THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

SRS Capital Advisors, Inc.'s Holding History (CIK: 0001586767)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 6 Value ($000) $0 Avg Close $16.59 Range $13.50 - $20.33

Q3 2025

Shares 226 Value ($000) $3 Avg Close $12.64 Range $10.82 - $14.87

Q3 2024

Shares 57 Value ($000) $0 Avg Close $8.66 Range $7.44 - $10.42

Q2 2024

Shares 57 Value ($000) $0 Avg Close $9.03 Range $8.13 - $10.44

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	6	$0	$16.59	$13.50 - $20.33
Q3 2025	226	$3	$12.64	$10.82 - $14.87
Q3 2024	57	$0	$8.66	$7.44 - $10.42
Q2 2024	57	$0	$9.03	$8.13 - $10.44